Imlifidase have a conditional approval in Europe since 2020. PAES (NCT05369975) is a controlled, non-randomized, open-label post-authorization efficacy and safety trial, designed to provide ...

SAN FRANCISCO, Oct. 23, 2026 /PRNewswire/ -- Jerry Garcia's family, in partnership with archival media management platform ...

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England ...

KBRA assigns preliminary ratings to five classes of notes issued by Foundation Finance Trust 2026-2 (“FFIN 2026-2”), an asset-backed securitization collateralized by unsecured consumer loans primarily ...

Ionis partner Roche announces new Phase 3 data showing sefaxersen significantly reduced proteinuria in people with IgA ...

Genentech Presents Interim Phase III Data Showing Sefaxersen Significantly Reduced Proteinuria in People With IgA Nephropathy (IgAN) ...

On May 11, 2026, the Company filed with the SEC a notification of late filing which disclosed it had "terminated the ...

NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, today announced Anthony Palladino as Chief Financial Officer.

The average global crude-oil freight rate has recently surged to more than $20/bbl higher than the level during the same time ...

The board of directors of Macy's, Inc. (NYSE: M) today declared a regular quarterly dividend of 19.15 cents per share on Macy's, Inc.’s common stock, payable on January 4, 2027, to shareholders of ...

U.S. stocks fell as oil prices continued to climb as concerns mounted that the U.S.-Iran conflict could soon escalate. Consumer Sentiment Declined Slightly in October The University of Michigan survey ...

Lyntris will report third quarter results on November 4 and host a live webcast with executive management.